Doctor of Dentistry Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Thomas Stone

Dentist, Oral and Maxillofacial Surgery Englewood, CO Doctor of Dentistry

NPI 1972609667 CMS profile 316092

3701 S Clarkson St, Suite 300, Englewood, CO 80113

Open in the dashboard

General payments

$117,380

152 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Thomas Stone of Englewood, CO is reported in the CMS Open Payments database as having received $117,380 across 152 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Dentist, Oral and Maxillofacial Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $928 16
2024 General $41,361 23
2023 General $21,028 28
2022 General $11,328 20
2021 General $22,117 22
2020 General $16,561 32
2019 General $4,055 11

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Thomas Stone
  • Dentist, Oral and Maxillofacial Surgery median
  • Middle half of Dentist, Oral and Maxillofacial Surgery
  • National median

In program year 2025, general payments to Thomas Stone were reported at $928. Among 3,834 Dentist, Oral and Maxillofacial Surgery profiles paid that year, the median was $150 and the middle half received between $56 and $423.

Show as a table
Year Thomas Stone Dentist, Oral and Maxillofacial Surgery median Middle half National median
2019 $4,055 $142 $50–$420 $163
2020 $16,561 $96 $36–$277 $114
2021 $22,117 $138 $45–$419 $132
2022 $11,328 $144 $48–$367 $149
2023 $21,028 $153 $55–$399 $160
2024 $41,361 $152 $50–$400 $164
2025 $928 $150 $56–$423 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Straumann USA LLC $114,719 94 payments
  2. Nobel Biocare USA $1,107 26 payments
  3. BioHorizons Implant Systems Inc. $1,004 17 payments
  4. Zimmer Biomet Holdings, Inc. $389 8 payments
  5. Ormco Corporation $110 4 payments
  6. Biofrontera Inc. $29 1 payment
  7. 3M Company $15 1 payment
  8. Salvin Dental Specialties, Inc. $7 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Honoraria $60,200 13 payments
  2. Gift $22,207 43 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $18,600 4 payments
  4. Travel and Lodging $12,600 10 payments
  5. Food and Beverage $3,648 77 payments
  6. Education $125 5 payments
Products named General payments · program years 2019–2025
  1. NOBELACTIVE $901 23 payments
  2. BioHorizons Dental Implants $773 13 payments
  3. BIOHORIZONS Implant Dentistry $231 4 payments
  4. BIOHORIZONS Implant Dentistry $231 4 payments
  5. BIOHORIZONS Implant Dentistry $231 4 payments
  6. BIOHORIZONS Implant Dentistry $231 4 payments
  7. BIOHORIZONS Implant Dentistry $231 4 payments
  8. Dental Product Portfolio $186 3 payments
  9. All T3 Implants $126 1 payment
  10. CREOS XENOGAIN $110 4 payments
  11. Other $290 12 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 6 drugs

Part D claims

774

Median for Oral Surgery (Dentist only): 288

Drug cost

$4,847

Median for Oral Surgery (Dentist only): $1,122

Branded share of claims

36.7%

Median for Oral Surgery (Dentist only): 18.4%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Amoxicillin-Clavulanate Potass Amoxicillin/Potassium Clav Brand 245 $2,093
Chlorhexidine Gluconate Generic 229 $1,523
Oxycodone Hcl Generic 225 $597
Cefuroxime Cefuroxime Axetil Brand 39 $462
Methylprednisolone Generic 12 $87
Amoxicillin Generic 24 $84

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 5,440 Part D prescribers listed as Oral Surgery (Dentist only); they describe a distribution and say nothing about conduct.

Records

152 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Dentist, Oral and Maxillofacial Surgery in Colorado

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record